A DOUBLE-BLIND, MULTI-SITE, RANDOMIZED STUDY EVALUATING THE EFFICACY AND SAFETY OF PCV15 IN THE PREVENTION OF ACUTE OTITIS MEDIA (AOM) IN INFANTS AND TODDLERS (PNEU-ERA) (ID 850)
MSD (UK)
This work was previously presented at ISPPD-14 in Copenhagen, Denmark, on 17-21 May 2026
Funding: This project was funded by Merck & Co., Inc., Rahway, NJ, USA
Conflicts of interest: Alvino Maestri, Muhammed Waleed, Yaru Shi, James Young, Tina Sterling, Dana Simcox, Tulin Shekar, Robert Lupinacci, Luwy Musey, Natalie Banniettis are employees of Merck & Co., Inc., Rahway, NJ, USA; Jayme Patel is an employee of MSD (UK) Limited, London, UK